Beleggen.nl Markt MonitorMarkt Monitor

Altice Terug naar discussie overzicht

Altice Europe Februari 2019

424 Posts
Pagina: «« 1 ... 17 18 19 20 21 22 | Laatste | Omlaag ↓
  1. UpandDown 1 maart 2019 10:09
    Ik heb liever dat het rustig aan stijgt en dan eind van de dag een eindsprint maakt. In plaats van een grote stijging in de ochtend en dan alles weer zien verdampen in de loop van de dag. Zo vaak is dat het geval geweest de afgelopen weken
  2. [verwijderd] 1 maart 2019 10:15
    quote:

    UpandDown schreef op 1 maart 2019 10:09:

    Ik heb liever dat het rustig aan stijgt en dan eind van de dag een eindsprint maakt. In plaats van een grote stijging in de ochtend en dan alles weer zien verdampen in de loop van de dag. Zo vaak is dat het geval geweest de afgelopen weken
    Dat klopt. Als het maar stijgt :)
  3. UpandDown 5 maart 2019 17:13
    Omwisselen naar het FransAOF) - Although the competitive environment has improved since the third quarter of 2018 in the telecoms sector in France, a sustainable operator discipline remains uncertain. This is what Barclays observes, which paints a gloomy picture of the sector. Thus, Iliad (-2.89% to 90.60 euros), Altice (-8.97% to 1.88 euros) and Bouygues (-1.10% to 32.48 euros) are penalized on the place of Paris . For its part, Orange (+ 0.11% to 13.33 euros) resists this pessimistic view.
    Describing "irrational" promotions during the fiscal year, Barclays believes that "prolonged healing of the market is necessary" to protect the profitability of the sector.
    But the durability of this healing is uncertain with four players, who have contradictory objectives according to the broker: gain market share for Iliad and Bouygues, protection of market share for Orange, and finally return to the stabilization of revenues for Altice.
    In this context, Barclays expects the turnover of the French market in 2019 to deteriorate compared to 2018 and is at the lower end of the spectrum compared to its European peers.
    With this in mind, the analysis office posts its caution for 2019, and downgraded certain recommendations.
    Thus, Orange and Iliad switch from Overweight to Neutral, with respective price targets adjusted from 18.50 to 16.50 euros, and from 145 to 105 euros.
    Orange withstood competitive pressure in 2018 thanks to its difference based on quality, but the year 2019 should prove more difficult underlines Barclays.
    As for Iliad, the group has launched new initiatives to better segment its market and is investing heavily in 4G coverage and FTTH. "However, catching the 4G bandwidth, and therefore the perception of quality, will take time," said the British bank.
    For its part, Altice goes from Neutral to Underweight, and sees its price target passed from 2.80 to 1.5 euro, after a difficult year operationally.
    Only Bouygues keeps his advice Neutral, and sees his price target adjusted from 39 to 37 euros.
    Faced with this dark vision of the future of French telecoms, Barclays believes that the consolidation of the market would be the best option, even if it seems unlikely in the short term.
424 Posts
Pagina: «« 1 ... 17 18 19 20 21 22 | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.102
AB InBev 2 5.529
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.951
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.807
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.782
Aedifica 3 925
Aegon 3.258 323.007
AFC Ajax 538 7.088
Affimed NV 2 6.303
ageas 5.844 109.897
Agfa-Gevaert 14 2.062
Ahold 3.538 74.345
Air France - KLM 1.025 35.250
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.048
Alfen 16 25.107
Allfunds Group 4 1.514
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 409
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.638
AMG 971 134.102
AMS 3 73
Amsterdam Commodities 305 6.740
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.031
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.789
Arcelor Mittal 2.034 320.895
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.342
Aroundtown SA 1 221
Arrowhead Research 5 9.750
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.564
ASML 1.766 109.563
ASR Nederland 21 4.506
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.735
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.439